Microbot Medical

Yahoo Finance • 2 days ago

Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System

HINGHAM, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and manufacturer of the innovative LIBERTY® Endovascular Robotic System, announces that its Chief Executive Officer, Harel Gadot, will be... Full story

Yahoo Finance • 6 days ago

Microbot (MBOT) Extends 4-Day Decline on $63-Million Fundraising Program

We recently published 10 Stocks Losing Big Amid Market Boom. Microbot Medical Inc. (NASDAQ:MBOT) is one of the worst performers on Thursday. Microbot extended its losing streak to a fourth consecutive session on Thursday, shedding 6.93 pe... Full story

Yahoo Finance • 9 days ago

Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

HINGHAM, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) (“Microbot” or the “Company”), today announced the first closing of its previously announced exercise of certain outstanding preferred investment opt... Full story

Yahoo Finance • 10 days ago

Monday's session: gap up and gap down stocks

Let's delve into the US markets on Monday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks. [gap] TOP GAP UP STOCKS TICKER CHANGE COMMENT NAOV [ht... Full story

Yahoo Finance • 16 days ago

REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference

HINGHAM, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and manufacturer of the innovative LIBERTY® Endovascular Robotic System, today announced that Harel Gadot, CEO, President & Chairman, will... Full story

Yahoo Finance • 17 days ago

Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System

Accelerated Launch Readiness Plans Position Company for Commercialization during Q4 2025 The Company’s Initial Addressable Market Includes Approximately 2.5 Million Peripheral Endovascular Procedures in the U.S. Annually CEO, President &... Full story

Yahoo Finance • last month

Brenmiller Energy appoints Harel Gadot as independent director to board

Brenmiller Energy Ltd . (NASDAQ:BNRG) announced Thursday the appointment of Harel Gadot as an independent director to its board, effective immediately. The decision was made by the company’s board of directors and fills a vacancy that will... Full story

Yahoo Finance • last month

Microbot Medical stock maintains Buy rating at H.C. Wainwright on patent win

Investing.com - Microbot Medical (NASDAQ:MBOT) maintained its Buy rating and $9.00 price target at H.C. Wainwright following a new patent grant for its LIBERTY endovascular robotic system. The stock has shown remarkable momentum, surging o... Full story

Yahoo Finance • last month

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications

With the Newly Granted IP, the Company’s IP Portfolio for the LIBERTY®System now includes 12 patents granted globally and 57 patent applications pending. The Company Continues to Scale Commercial Readiness Plans for the LIBERTY®System as... Full story

Yahoo Finance • 2 months ago

DIH Appoints Scott R. Burell to DIH Holding US, Inc. Board of Directors

NORWELL, Mass., Aug. 08, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable cl... Full story

Yahoo Finance • 2 months ago

Microbot Medical appoints former Olympian as VP of sales

HINGHAM, Mass. - Microbot Medical Inc. (NASDAQ:MBOT), whose stock has surged over 130% in the past year, has appointed Christina Bailey as its new Vice President of Sales, according to a company press release issued Tuesday. Bailey, a two... Full story

Yahoo Finance • 2 months ago

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales

Microbot Medical Inc. Company Continues to Strengthen Organizational Infrastructure with Success-Driven Medical Device Veteran Christina Bailey, VP of Sales, Microbot MedicalMicrobot Medical® Expands Commercial Leadership with Appointmen... Full story

Yahoo Finance • 3 months ago

Microbot Medical Secures China Patent for LIBERTY System, Eyes Q3 2025 US Launch

Microbot Medical Inc. (NASDAQ:MBOT) is one of the best-performing NASDAQ stocks according to analysts. On June 17, Microbot Medical announced that it had been granted a patent in China by the China National Intellectual Property Administra... Full story

Yahoo Finance • 3 months ago

Microbot Medical® Added to the Russell Microcap® Index

HINGHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, announced that it was added as a member of the Russell Microcap® Index. Microbot Me... Full story

Yahoo Finance • 3 months ago

Microbot Medical receives patent in China for surgical robotics

HINGHAM, Mass. - Microbot Medical Inc. (NASDAQ:MBOT), a medical robotics company whose stock has surged over 140% in the past six months, has been granted a patent in China by the China National Intellectual Property Administration for rob... Full story

Yahoo Finance • 4 months ago

Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index

HINGHAM, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, announced that it has been selected for inclusion in the preliminary list of additi... Full story

Yahoo Finance • 5 months ago

Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers

The addition of a seasoned VP of Marketing compliments the recent hiring of the Company’s VP of Sales to establish its commercialization readiness infrastructure Positive data from the recently published pivotal study raises confidence th... Full story

Yahoo Finance • 5 months ago

Global Robotic Exoskeleton Market Size Expected to Reach $30 Billion By 2032 as A.I. Influence Disrupts the Industry

PALM BEACH, Fla., April 15, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Industry experts project that the wearable robotic exoskeleton market, which has experienced notable growth over the past decade, driven by advancement... Full story

Yahoo Finance • 6 months ago

Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System

Successful robotic navigation was achieved in every case and met the primary endpoint of the study LIBERTY® showed a 92% reduction in radiation exposure with no adverse events reported HINGHAM, Mass., April 09, 2025 (GLOBE NEWSWIRE) --... Full story

Yahoo Finance • 7 months ago

Microbot Medical Closes $13 Million Registered Direct Offering

BRAINTREE, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale... Full story